AU Patent

AU2020213351A1 — Methods of treating ocular conditions

Assigned to Oyster Point Pharma Inc · Expires 2020-08-27 · 6y expired

What this patent protects

WO 2016/064759 PCT/US2015/056273 1/1 Figure 1 20 E 15 ti Figure 2 10 E N -5 4" Placebo OC-01 Abstract: Described herein are methods and pharmaceutical formulations for treating ocular conditions. See Fig. 1.

USPTO Abstract

WO 2016/064759 PCT/US2015/056273 1/1 Figure 1 20 E 15 ti Figure 2 10 E N -5 4" Placebo OC-01 Abstract: Described herein are methods and pharmaceutical formulations for treating ocular conditions. See Fig. 1.

Drugs covered by this patent

Patent Metadata

Patent number
AU2020213351A1
Jurisdiction
AU
Classification
—
Expires
2020-08-27
Drug substance claim
No
Drug product claim
No
Assignee
Oyster Point Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.